Clinical trial evaluating dendritic cell vaccination as an adjuvant immunotherapy in patients with pancreatic cancer
Not Applicable
Recruiting
- Conditions
- Pancreatic cancer
- Registration Number
- JPRN-UMIN000009994
- Lead Sponsor
- Yokohama City University, Gastroenterological Surgery
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
(1)Patients with sighs or history of interstitial pneumonia. (2)Patients with autoimmune diseases. (3)Patients with uncontrolable infectious diseases. (4)Patients with history of severe heart diseases. (5)Patients with history of severe drug allergy. (6)Patients received continuous administration of steroids. (7)Patients with pregnant or probability of pregnancy or breast-feeding. (8)Patients with HIV or HTLV-1 infection in 6 months. (9)Patients considered inadequate for this trial by physician-in-charge.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tumor-specific immune responses
- Secondary Outcome Measures
Name Time Method Relapse free survival Overall survival Tumor marker Quality of life